Isosorbide Dinitrate and Hydralazine and Moxetumomab pasudotox
Determining the interaction of Isosorbide Dinitrate and Hydralazine and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydralazine / isosorbide dinitrate
Brand name: BiDil
Synonyms: Hydralazine and isosorbide dinitrate
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Isosorbide Dinitrate and Hydralazine-Moxetumomab Pasudotox-tdfk
- Isosorbide Dinitrate and Hydralazine-Moxetumomab pasudotox-tdfk Intravenous
- Isosorbide Dinitrate and Hydralazine-Moxifloxacin
- Isosorbide Dinitrate and Hydralazine-Moxifloxacin (Systemic)
- Isosorbide Dinitrate and Hydralazine-Moxifloxacin Hydrochloride
- Isosorbide Dinitrate and Hydralazine-Moxifloxacin Injection
- Moxetumomab pasudotox-Isosorbide Dinitrate Extended-Release Capsules and Tablets
- Moxetumomab pasudotox-Isosorbide dinitrate Oral, Sublingual
- Moxetumomab pasudotox-Isosorbide Dinitrate Tablets
- Moxetumomab pasudotox-Isosorbide mononitrate
- Moxetumomab pasudotox-Isosorbide Mononitrate Extended Release
- Moxetumomab pasudotox-Isosorbide Mononitrate Extended-Release Tablets